Poland · Delayed Price · Currency is PLN Krynica Vitamin Statistics
Total Valuation
Krynica Vitamin has a market cap or net worth of PLN 131.08 million. The enterprise value is 160.85 million.
| Market Cap | 131.08M |
| Enterprise Value | 160.85M |
Important Dates
The last earnings date was Thursday, September 24, 2026.
| Earnings Date | Sep 24, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
Krynica Vitamin has 12.25 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 12.25M |
| Shares Outstanding | 12.25M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 821,000 |
Valuation Ratios
The trailing PE ratio is 15.36.
| PE Ratio | 15.36 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.62 |
| P/FCF Ratio | 20.01 |
| P/OCF Ratio | 8.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.40, with an EV/FCF ratio of 23.72.
| EV / Earnings | 18.21 |
| EV / Sales | 0.51 |
| EV / EBITDA | 5.40 |
| EV / EBIT | 9.04 |
| EV / FCF | 23.72 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.41.
| Current Ratio | 0.95 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 1.16 |
| Debt / FCF | 5.11 |
| Interest Coverage | 11.19 |
Financial Efficiency
Return on equity (ROE) is 10.52% and return on invested capital (ROIC) is 13.62%.
| Return on Equity (ROE) | 10.52% |
| Return on Assets (ROA) | 5.43% |
| Return on Invested Capital (ROIC) | 13.62% |
| Return on Capital Employed (ROCE) | 18.27% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | 1.07M |
| Profits Per Employee | 29,857 |
| Employee Count | 350 |
| Asset Turnover | 1.54 |
| Inventory Turnover | 7.23 |
Taxes
In the past 12 months, Krynica Vitamin has paid 2.03 million in taxes.
| Income Tax | 2.03M |
| Effective Tax Rate | 16.25% |
Stock Price Statistics
The stock price has increased by +29.70% in the last 52 weeks. The beta is 0.07, so Krynica Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | +29.70% |
| 50-Day Moving Average | 13.05 |
| 200-Day Moving Average | 12.11 |
| Relative Strength Index (RSI) | 52.85 |
| Average Volume (20 Days) | 373 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Krynica Vitamin had revenue of PLN 373.59 million and earned 10.45 million in profits. Earnings per share was 0.85.
| Revenue | 373.59M |
| Gross Profit | 63.90M |
| Operating Income | 21.04M |
| Pretax Income | 12.48M |
| Net Income | 10.45M |
| EBITDA | 35.25M |
| EBIT | 21.04M |
| Earnings Per Share (EPS) | 0.85 |
Balance Sheet
The company has 11.20 million in cash and 40.97 million in debt, with a net cash position of -29.77 million or -2.43 per share.
| Cash & Cash Equivalents | 11.20M |
| Total Debt | 40.97M |
| Net Cash | -29.77M |
| Net Cash Per Share | -2.43 |
| Equity (Book Value) | 100.80M |
| Book Value Per Share | 8.23 |
| Working Capital | -5.96M |
Cash Flow
In the last 12 months, operating cash flow was 19.85 million and capital expenditures -11.83 million, giving a free cash flow of 8.02 million.
| Operating Cash Flow | 19.85M |
| Capital Expenditures | -11.83M |
| Depreciation & Amortization | 14.22M |
| Net Borrowing | -7.40M |
| Free Cash Flow | 8.02M |
| FCF Per Share | 0.65 |
Margins
Gross margin is 17.10%, with operating and profit margins of 5.63% and 2.80%.
| Gross Margin | 17.10% |
| Operating Margin | 5.63% |
| Pretax Margin | 3.34% |
| Profit Margin | 2.80% |
| EBITDA Margin | 9.44% |
| EBIT Margin | 5.63% |
| FCF Margin | 2.15% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.52%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 2.52% |
| Dividend Growth (YoY) | 129.63% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 31.66% |
| FCF Payout Ratio | 94.70% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 6.51% |
| FCF Yield | 5.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Krynica Vitamin has an Altman Z-Score of 2.35 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.35 |
| Piotroski F-Score | 6 |